Detailed GuideMHRA
Safety Public Assessment Reports
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
First published: Jan 4, 2019Last updated: Jan 26, 2026Changes: 14
Latest change: Updated to add 'Review of risk minimisation for disabling and potentially long-lasting/irreversible side effects associated with fluoroquinolone antibiotics', 'Improving information supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs', and 'Review of the impact of recommendations for the prescribing of isotretinoin'
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.